We have changed our visitation policy for the safety of our patients and staff. Click here for the updated visitation policy and click here for information about COVID-19.

[LCID Study Number: 2018-065]

A Phase I Trial of Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer.

To see what effects, good and/or bad, the two study drugs have in combination on you and your prostate cancer. The study will look at what side effects you may have and how you feel when you are receiving study drug.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421